臨床微生物學- 細菌及黴菌學

(1)

ix

§

~

fi'f --~ i'i 1~fi

J·l=

)tl!f, 11:: 1_{1-7n :t.r~ ~:~·u"}

₍

_Ei~il*~₎

:;;or:t ·I • ltUU -1' I!M

-r.

1//.J '''•C.• llu ;IJ./ Ill% n

11

is

.e.A 2

- /111~' Plffl

1-2

f

,~

:r

1Ah

:1t

~ ~ ~JlJff01HiJJL~ 27

*-~:,·;'t ~X ~iJi

(

**~~B

,

5~2ff!()

2-1

-Ax

'~i jf (General Characteristics) 32 2-2 ~~

!-*

;t

i

(Clinical Significance) 33

2-3 ±:§'lH~ '~i§dtlt:t 5! (Cultural Characteristics & Identification) 44

m.=..:~~ -"r~l¥i~I~M'I"t.f¥1~i-- --1tU~Uf¥rW~HHI~1*-Illr~i

(

Dllfii~)

3-1 -

AHi

jf (General Characteristics) 52 3-2 ~~Jt:ti (Clinical Significance) 54

3-3

±:§'

lH~ '~i2:?dtlt:7J 5! (Cultural Characteristics & Identification) 54

3-4 ~

#J

~ ~ '~i~J\,~ (Antimicrobial Susceptibility Testing) 56 3-5 tfi ~;? / ~tf.it ~ ~ (Prevention I Epidemiology) 58

3-6 ~ 17~ 1i}f

JE

(Case Study) 59

miZY'~: lf'~l¥1 ~I~M·I'!f:.f*l~i--- --&fli!M~r~irrr~

(

DBfii~)

4-1

-Ax

'~i jf ( General Characteristics ) 62 4-2 ~~

!-*

;t

i

4-3 ±:§'lH~ti,&Jtlt:7J:'l! (Cultural Characteristics & Identification) 64

4-4 ~

#J

~ ~ '~i ~J\,~ (Antimicrobial Susceptibility Testing) 66

4-5 tfi ~;? /

Y;l

it~~ (Prevention I Epidemiology) 67 4-6 ~ 17~ 1i}f

JE

(Case Study) 67

m

li~ :lJ~lll.E\JbH'JJ;R l~i -JJMM~

r¥i

& Jt

iillf1aal

1

~iJ~t'IJ4( r~i

(

~~~~R)

5-1

-Ax

'~i jf ( General Characteristics ) 72

5-2 ~~

!-*

;t

i

5-3

±:§'

w

4~ '~1.&.

tJ.

Jt

:7J

5!

(Cultural Characteristics & Identification) 7 4

5-4 ~

#J

4W_ ~ '~i ~J\,~! (Antimicrobial Susceptibility Testing) 78 5-5 tfi ~;? / ~tf. it~~ (Prevention I Epidemiology) 81

(2)

•

II

•

I I II If ~ I /I

5-6 1W 1Y~ 1l)f

9'E (

Case Study) 81

tr1 /\ ,·;·;:

tp.

r~LL\: ~~~

'I''IJ*

(ii

'i~ ~J

\:

f¥

l~ila\J

fll

~Hit. !:~

1\:

hJ~ 1~i

M.J (

5~~~

)

- - - " - ---·-~

6-1 - ~9Ji j!f ( General Characteristics ) 86

6-2 ~£

Jt!::

i

6-3 ±:§'w4~'tiEdltJ:t7J)i- (Cultural Characteristics & Identification) 88

6-4 ~#I

&&

'J:_

'ti

~;\.~ (Antimicrobial Susceptibility Testing) 89

6-5

tJl

fl7J / ~t

if

1W ~ (Prevention I Epidemiology) 90 6-6 1W 1Y~ 1l)f

9'E

(Case Study) 91

l

7-1 -

f-J93i

j!f ( General Characteristics) 96

7-2 ~£

!t!::

i

7-3 ±:§'w4~·tiEd1Ut7J:Yt- (Cultural Characteristics & Identification) 98

7-4 fi_

#I &&

'J:_

·ii

7-5

tJl

~jj / ~t

if

9'E (

Case Study ) 1 02

,_,. ' ' . It· 'r'' r('.,l_ll

'I''I·J:fl "'

lh'rll '' f ~ - I .J: I ' ' t 1

~}/\.•','( •t•-1;,41.1-\.}'l/i. :TI'I~I }~.~r1.fl~i1;11i!!Hd:T1FI*i'tl'a (~.1-.:l.IE)

- - - " ·-"

-8-1 -

f-1931.

j!f (General Characteristics) 106

8-2 ~£

!t!::

i

8-3 ±:§'w4~·ti.&tLJ:t7T:Yt- (Cultural Characteristics & Identification) 107

8-4 fi_

#I &&

'J:_

'ti

8-5

tJl

~jj / ~t

if

9'E (

Case Study) 111

;:_r} JL

.·;·~ ~~~~:l:~g_SJ~Htl'((ii

__

J_tiWii.\J (

~.1-.:l.IE)

9-1 -

f-19: ·ti

j!f ( General Characteristics ) 114

9-2 ~£

!t!::

i

9-3

±:§' w

4~

·ti.&

It

Jt

jJ

5!-

(Cultural Characteristics & Identification) 116

9-4 fi_

#I &&

'J:_

·ti

9-5

tJl

~jj / ~t

if

1W ~ (Prevention I Epidemiology) 118 9-6 1W 17~ 1l)f

9'E (

Case Study) 120

(3)

'ff'ii-""~

717 Xj't.

t(r:frJ

.E\:I)Mi'l"f:f't!r!ii---71'--tkt'i!IWJt:J C

fflll-Y-lE)

10-1 - ~9:.

'i:i

1{ ( General Characteristics ) 122 10-2 ~Jh !t

;t

~ (Clinical Significance) 123

10-3

±§

iHf'fiEz.~.R:;lf )!- (Cultural Characteristics & Identification) 127 10-4 ~ !fiiJ ~ ~'fit~,~ (Antimicrobial Susceptibility Testing) 138

10-5 t~ [l;ij / :;!)[

1-T

~

*

(Prevention I Epidemiology) 144 10-6 ~ 17~ 1i}f

JE

(Case Study) 146

k l r 1 -u";_

~-r-~ ~ct. -rr·-,~,.1-u:l'~'l"'·l:III!fl• _{~t·· il!i J--\. l;z:~} 1:: T'f ;f; ---- n~Yf 1-~<lr~r Jft' H~.t-1:11 ,,.f'l

c-

J

''IJ!

-:t+-)

11-1 - ~

'fi

1{ (General Characteristics) 150 11-2 ~Jh

!t

;t

11-3

±§

:li~ 'fiR.~

.R

:;& )!- ( Cultural Characteristics & Identification) 162 11-4 ~ !fiiJ ~~'fit~~~ (Antimicrobial Susceptibility Testing) 171

11-5 t~ [l;ij /~tiT~* (Prevention I Epidemiology) 171 11-6 ~ 17~ 1i}f

JE (

Case Study) 171

%

i

·-=·~lit

:{(.:

fM1

1:\:

~

'1"1:

f!rl~i

- - -

Jr

tm

~~1-t'H',~

(ii

Oit~~~

)

12-1 -~Hi 1{ ( General Characteristics ) 17 6 12-2 ~JJ;;t;t~ (Clinical Significance) 178

12-3

±§

:li~ 'fiEz.~.R:;lf )!- (Cultural Characteristics & Identification) 179 12-4 ~ !fiiJ ~ ~

'fi

t~~~t (Antimicrobial Susceptibility Testing) 187

12-5 t~ P;? / ~t

1-T

~

*

(Prevention I Epidemiology) 188 12-6 ~ 17~ 1i}f

JE

(Case Study) 189

NIT· J_.. ---.-n:. -u·-~ .. LCj(~

l''j·-1:1' .,.

~~~

... ,.'

c / _ _. '-"'!l{.r ... "'].' "''·

t'

1:11 ... ,.'

~--, _:_:_::_rf't. W[Kil.L-~Jif.:n~I~I- -'Jh.\l--f'll--f'l~~1 ... l'l ~<t11'-rJtil-f<llr<ll\'U' ·r·~lthFI~fl-f'JtiJ

(

~fiitif)

13-1 - ~

'fi

1{ (General Characteristics) 194 13-2 ~

!t

;t

13-3 ±§:liHiEz.~.R:;lf )!- (Cultural Characteristics & Identification) 199 13-4 :k;l (Treatment) 202

13-5 t~ [l;ij / ~

1-T

~

*

(Prevention I Epidemiology) 203 13-6 ~ '[Y1j 1i}f

JE

(Case Study) 204

(4)

14-3 ±'ii:fH~'tiEdl!Ut:lJ:Y! (Cultural Characteristics & Identification) 221 14-4 ~WHi!J ~ ~ ti~J\,~t (Antimicrobial Susceptibility Testing) 233

A

14-5

tUJJ / 5}\E iT

m"

(Prevention I Epidemiology) 235

~ 14-6 m1:Jij

1i}f%

(Case Study) 236

~

~~

;f}

I ·

Ji.

j'if.

lUX

'r~t.

'1''1:

•'t'~

IUiH\":

~~~'1''1: ~UII~i O~B~Jt

)

P

15-1 -~xti Ji[ (General Characteristics) 242

II _;1 _15-2 _~Jb

_"*-

_;t_~_{(Clinical Significance)} ₂₄₂

5

II

5

II

5

~

15-3

±:g

:fH~

tibt !Ut :7J

5!

(Cultural Characteristics & Identification) 244 15-4 ~

4iv

~ ~

ti

~J\,~t (Antimicrobial Susceptibility Testing) 24 7

15-5

tfi

~jj /~tiT

ffl"

(Prevention I Epidemiology) 248 15-6 m1:7~

1iJf%

(Case Study) 248

5 ~Lt!:~ ,,~,t~ lUX~-:\ t'l:ir~ l~i

.1:\:

I~

'1''1:

~llll~t

c

~5k&~

)

16-1 -~X

ti

Ji[ (General Characteristics) 252 16-2 ~Jb

"*-

;t ~ (Clinical Significance ) 253

16-3 ±'1i~4~'tibtti5t:7J:Y! (Cultural Characteristics & Identification) 254 16-4 ~tiv ~ ~'ti~J\,~ (Antimicrobial Susceptibility Testing) 261

16-5 5{1 ~ /

tfi

~jj ( Treatment/Prevention ) 261 16-6 m1:Jlj

1i}f% (

Case Study) 262

17-1 -~X

'ti

J![ ( General Characteristics ) 266 17-2 ~Jb

"*-

;t ~ (Clinical Significance) 266

17-3 ±:fj~4~'tibtti5t:7J

5!

(Cultural Characteristics & Identification) 267 17-4 ~

4iv

~ ~

'ti

~J\,~ (Antimicrobial Susceptibility Testing) 268

17-5

tfi

~jj (Prevention) 269 17-6 m1:7~

1iJf% (

Case study) 269

~}·I·!\ ~~t

ti:&

~it

1¥i

J~J

,

J,J~ ~ii l~i J~~

C

AA)t~~

)

---·---~---- - · ·

(5)

xiii

18-2 ~£

JR

18-3 J~:tt-4~

'fi2?dt;t:7J

51;; (Cultural Characteristics & Identification) 274 18-4 ~4&1 ~ 'Jt'ti~~~ (Antimicrobial Susceptibility Testing) 275

18-5

tJH7

(Prevention ) 2 7 5 18-6 #]

17rJ

1i}f

JE

(Case Study) 275

~lf~JL ··~.:

fi!i.i\l:iiJr;,j '

\'r:

1C:~j\l'f.~nli~

'

rnJ

:/C:Wr JX:mVr;J

C

Mt)t~)

19-1 -

RHi

J[ (General Characteristics) 280 19-2 ~£

JR

19-3 ±f§

1t-

4~ 'fill~

;t

:7i

51;; (Cultural Characteristics & Identification) 281 19-4 ~ 4&1 ~ '§t

'ti

~~~ (Antimicrobial Susceptibility Testing) 282

19-5

tJi

rJJ

(Prevention) 283 19-6 #] 17~ 1i}f

JE

(Case Study) 283

~1~.-f·~~'r: ~SbJ*fl~r¥1 c~~Iti~, ~!fa~~~)

20-1

-R9Ji

J[ (General Characteristics) 288 20-2 ~£

JR

20-3 ±:t§ :tt-4~ 'rill~

Jtli

51;; (Cultural Characteristics & Identification) 297 2 0-4

#c

flt

"I

~ 4&1 ( Anti fungal Agents ) 3 0 I

20-5

H3

'1i /

tW

llJJ /

).m,

1-T

~

*

(Treatment/Prevention /Epidemiology) 302 20-6

11 "If

~it

i:

{t r-'j (Techniques in Mycology Lab) 303

20-7 #] 17~ 1i}f

JE

(Case Study) 305

*

=·

-l-

-t;'(

tiff~~'': ~m ~~ r¥~ M~

'Sl:

t'l:.'i,r\J.~~

c

~~~

)

21-1 -

M

'ti

J[ ( General Characteristics ) 3 08

21-2

tiL

::i

t

Z. 11' ffl11

~ (Mechanisms of Antibiotic Resistance) 308 21-3

tiL

~'iiZ.11:M (Mechanisms of Antibiotic Resistance) 313 21-4 ~ 4&1 ~ '§t

'ii

~~~t (Antimicrobial Susceptibility Test) 316 21-5

#J17rJ1i)fJE

(Case Study) 328

,..,..

~

f

--~ .·;',~

*~--·---'it

_lt'C

_IAJ

!li.~

* (

tii~fi

₎

22-1 ~~ 332

22-2 Jl7t

pq

~

?4df-J

?J~ ~J!

ll

Y)c

*

333

(6)

I

22-6 f¥3H~-89~~ll, :PJt~J?d!fD:f 337

22-7

m

17~ 1i}f

JE (

Case Study ) 3 3 9

I)H

~

~H~-

:

1. 4?o

't:-

~it

1'f

ill

343

m•~:m~~1.4?o~#~~~~£~z..~•

3«

m•~:fl7tP9M*'~•&~~~• 3® m•~:~~~~J£~-~~ 3M ~H~ Ji : #-ts ~ 77\_ :M f.~

1i'-

3 6 7 ~:>c %'~I 373 r:f:>c%'~1 386

臨床微生物學- 細菌及黴菌學

§

~

J·l=

(

-r.

is

f

:r

1Ah

:1t

*-~:,·;'t ~X ~iJi

(

**~~B

,

5~2ff!()

-Ax

!*-

;t

i

m.=..:~~ -"r~l¥i~I~M'I"t.f¥1~i-- --1tU~Uf¥rW~HHI~1*-Illr~i

(

Dllfii~)

AHi

±:§'

#J

JE

miZY'~: lf'~l¥1 ~I~M·I'!f:.f*l~i--- --&fli!M~r~irrr~

(

DBfii~)

-Ax

!*-

;t

i

#J

Y;l

JE

m

li~ :lJ~lll.E\JbH'JJ;R l~i -JJMM~

r¥i

& Jt

iillf1aal

~iJ~t'IJ4( r~i

(

~~~~R)

-Ax

!*-

;t

i

±:§'

w

tJ.

Jt

:7J

5!

#J

•

•

9'E (

tr1 /\ ,·;·;:

tp.

'I''IJ*

(ii

\:

f¥

fll

1\:

M.J (

)

Jt!::

i

&&

'ti

tJl

if

9'E

l

f-J93i

!t!::

i

₍

!-*

!-*

!-*